PubMed=23746426; DOI=10.1016/j.jneuroim.2013.03.003
Miyazaki-Komine K., Abe Y., Iwanari H., Suzuki Y., Kikuchi T., Ito T., Kato J., Kusano-Arai O., Takahashi T., Nishiyama S., Ikeshima-Kataoka H., Tsuji S., Arimitsu T., Kato Y., Sakihama T., Toyama Y., Fujihara K., Hamakubo T., Yasui M.
Establishment of monoclonal antibodies against the extracellular domain that block binding of NMO-IgG to AQP4.
J. Neuroimmunol. 260:107-116(2013)

PubMed=26637322; DOI=10.1186/s40478-015-0259-2; PMCID=PMC4670539
Kurosawa K., Misu T., Takai Y., Sato D.K., Takahashi T., Abe Y., Iwanari H., Ogawa R., Nakashima I., Fujihara K., Hamakubo T., Yasui M., Aoki M.
Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody.
Acta Neuropathol. Commun. 3:82.1-82.15(2015)

PubMed=26398585; DOI=10.1111/bph.13340; PMCID=PMC4813391
Miyazaki-Komine K., Takai Y., Huang P., Kusano-Arai O., Iwanari H., Misu T., Koda K., Mitomo K., Sakihama T., Toyama Y., Fujihara K., Hamakubo T., Yasui M., Abe Y.
High avidity chimeric monoclonal antibodies against the extracellular domains of human aquaporin-4 competing with the neuromyelitis optica autoantibody, NMO-IgG.
Br. J. Pharmacol. 173:103-114(2016)